Abstract
Diffuse midline glioma, H3 K27M mutant, is newly recognized as a distinct category, which usually arises in the brain stem, thalamus or spinal cord of children, and young adults. The oncogenic H3 K27M mutation involves H3.3 (encoded by H3F3A) or H3.1 (encoded by HIST1H3B/HIST1H3C), and the incidence of each mutation differs among the primary sites. Recently, several papers have reported that cerebellar high-grade gliomas in both children and adults also harbor H3 K27 mutation. With the exception of one pediatric case, all of the cases carried the mutation in H3.3. We herein present the case of an adult cerebellar high-grade astrocytic tumor with H3.1 K27M mutation in a 45-year-old man, which also involvedTP53 mutation and was immunonegative for ATRX. Some groups have reported that H3.3 and H3.1 K27M mutations define subgroups of diffuse intrinsic pontine gliomas (DIPGs) with different phenotypes as well as genetic alterations. On comparing the findings of the present case, particularly TP53 mutation status and ATRX expression, to the findings of the previous studies on DIPGs, our case seems unusual among the H3.1 K27M mutant subgroup. Further studies are needed to clarify the exact frequency, clinicopathological characteristics, and genomic alterations of cerebellar gliomas harboring H3 K27M mutation.
Similar content being viewed by others
References
Hawkins CE, Ellison DW, Sturm D (2016) Diffuse midline glioma, H3 K27M-mutant. In: Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Ellison DW (eds) WHO Classification of Tumours of the Central Nervous System. IARC Press, Lyon, pp 57–59
Castel D, Phillipe C, Calmon R et al (2015) Histone H3F3A and HIST1H3B K27M mutations define two subgroups of diffuse intrinsic pontine gliomas with different prognosis and phenotypes. Acta Neuropathol 130:815–827
Wu G, Broniscer A, McEachron TA et al (2012) Somatic Histone H3 alterations in paediatric diffuse intrinsic pontine gliomas and non-brainstem glioblastomas. Nat Genet 44:251–253
Mackay A, Burford A, Carvalho D et al (2017) Integrated molecular meta-analysis of 1000 pediatric high-grade and diffuse intrinsic pontine glioma. Cancer Cell 32:520–537
Nakata S, Nobusawa S, Yamazaki T et al (2017) Histone H3 K27M mutations in adult cerebellar high-grade gliomas. Brain Tumor Pathol 34:113–119
Nomura M, Mukasa A, Nagae G et al (2017) Distinct molecular profile of diffuse cerebellar gliomas. Acta Neuropathol. https://doi.org/10.1007/s00401-017-1771-1
Venneti S, Garimella MT, Sullivan LM et al (2013) Evaluation of Histone 3 lysine 27 trimethylation (H3K27me3) and enhancer of zest 2 (EZH2) in pediatric glial and glioneuronal tumors shows decreased H3K27me3 in H3F3A K27M mutant glioblastomas. Brain Pathol 23:558–564
Watanabe K, Tachibana O, Sato K et al (1996) Overexpression of the EGF receptor and p53 mutations are mutually exclusive in the evolution of primary and secondary glioblastomas. Brain Pathol 6:217–224
Solomon DA, Wood MD, Tihan T et al (2016) Diffuse midline gliomas with Histone H3-K27M mutation: a series of 47 cases assessing the spectrum of morphologic variation and associated genetic alterations. Brain Pathol 26:569–580
Kinjo S, Yokoo H, Hirato J et al (2007) Anaplastic astrocytoma with eosinophilic granular cells. Neuropathol 27:457–462
Aboian MS, Solomon DA, Mabray MC et al (2017) Imaging characteristics of pediatric diffuse midline gliomas with histon H3 K27M mutations. AJNR. https://doi.org/10.3174/ajnr.A5076
Buczkowicz P, Hoeman C, Rakopoulos et al (2014) Genomic analysis of diffuse intrinsic pontine gliomas identifies three molecular subgroups and recurrent activating ACVR1 mutations. Nat Genet 46:451–456
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors have no conflicts of interest to declare.
Rights and permissions
About this article
Cite this article
Funata, N., Nobusawa, S., Nakata, S. et al. A case report of adult cerebellar high-grade glioma with H3.1 K27M mutation: a rare example of an H3 K27M mutant cerebellar tumor. Brain Tumor Pathol 35, 29–35 (2018). https://doi.org/10.1007/s10014-017-0305-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10014-017-0305-9